Robert William Sidwell

Robert William Sidwell's AcademicInfluence.com Rankings

Biology

#9343

World Rank

#12538

Historical Rank

Neuroscience

#1358

World Rank

#1404

Historical Rank

biology Degrees

Download Badge

Biology

Robert William Sidwell's Degrees

PhD Neuroscience Stanford University
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Robert William Sidwell Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert William Sidwell's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring (2003) (955)
Broad-Spectrum Antiviral Activity of Virazole: 1-f8- D-Ribofuranosyl- 1,2,4-triazole- 3-carboxamide (1972) (954)
Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. (1973) (468)
Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. (1972) (410)
Handbook of Animal Models of Infection (1999) (347)
Prenatal Viral Infection Leads to Pyramidal Cell Atrophy and Macrocephaly in Adulthood: Implications for Genesis of Autism and Schizophrenia (2002) (262)
Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice (1999) (258)
Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection (1998) (250)
Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection (2006) (225)
Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice (2006) (209)
Influenza virus resistance to neuraminidase inhibitors. (1998) (208)
Antiviral activities of biflavonoids. (1999) (194)
Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. (2003) (180)
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. (1998) (172)
Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities (2001) (169)
Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071 (1998) (166)
Identification of active antiviral compounds against a New York isolate of West Nile virus. (2002) (163)
Synthesis and antiviral activity of certain thiazole C-nucleosides. (1977) (162)
In Vitro Effect of 1-β-d-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Deoxyribonucleic Acid and Ribonucleic Acid Viruses (1973) (159)
Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice (2006) (150)
Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. (1992) (148)
Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. (1991) (145)
TLR3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection1 (2006) (140)
Inhibition of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and β-D-N4-Hydroxycytidine (2004) (132)
Demystifying the cost barriers to offsite construction in the UK (2011) (128)
Use of disposable micro tissue culture plates for antiviral and interferon induction studies. (1971) (126)
Ribavirin: an antiviral agent. (1979) (125)
Synthesis of cyclopentenyl carbocyclic nucleosides as potential antiviral agents against orthopoxviruses and SARS. (2006) (124)
Characterization of Wild-Type and Cidofovir-Resistant Strains of Camelpox, Cowpox, Monkeypox, and Vaccinia Viruses (2002) (123)
Effect of Interferon-Alpha and Interferon-Inducers on West Nile Virus in Mouse and Hamster Animal Models (2004) (122)
In vitro and in vivo assay systems for study of influenza virus inhibitors. (2000) (120)
In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections (2007) (119)
In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections. (2007) (117)
TLR3 Is Essential for the Induction of Protective Immunity against Punta Toro Virus Infection by the Double-Stranded RNA (dsRNA), Poly(I:C12U), but not Poly(I:C): Differential Recognition of Synthetic dsRNA Molecules1 (2007) (115)
In vitro and in vivo influenza virus-inhibitory effects of viramidine. (2005) (113)
Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice (2002) (107)
Prenatal viral infection causes alterations in nNOS expression in developing mouse brains (2000) (107)
A review of compounds exhibiting anti-orthopoxvirus activity in animal models (2003) (106)
In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201 (2001) (98)
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin (2006) (96)
Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza (2002) (95)
In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice (1991) (92)
Treatment of Lethal Vaccinia Virus Respiratory Infections in Mice with Cidofovir (2001) (90)
Error-prone replication of West Nile virus caused by ribavirin. (2005) (85)
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice. (2001) (82)
Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. (2002) (82)
In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses. (1968) (81)
Quantitative Studies on Fabrics as Disseminators of Viruses (1970) (73)
Heterocyclic Thiosemicarbazones: Correlation Between Structure, Inhibition of Ribonucleotide Reductase, and Inhibition of DNA Viruses 1 (1970) (72)
Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir. (2000) (70)
Respiratory syncytial virus infections: recent prospects for control. (2006) (69)
Activities of Oseltamivir and Ribavirin Used Alone and in Combination against Infections in Mice with Recent Isolates of Influenza a (H1N1) and B Viruses (2006) (69)
Effect of 1-β-d-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) on Herpes and Vaccinia Keratitis and Encephalitis in Laboratory Animals (1973) (69)
Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes. (1997) (68)
Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides. (1973) (68)
The role of cerebellar genes in pathology of autism and schizophrenia (2008) (68)
Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus. (2001) (63)
Neutralizing Viruses in Suspensions by Copper Oxide-Based Filters (2007) (63)
Suppression by 1-β-d-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) of Influenza Virus-Induced Infections in Mice (1973) (60)
In vitro and in vivo Phlebovirus inhibition by ribavirin (1988) (57)
Combination Treatment of Influenza A Virus Infections in Cell Culture and in Mice with the Cyclopentane Neuraminidase Inhibitor RWJ-270201 and Ribavirin (2002) (57)
Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. (2007) (56)
Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity (1982) (56)
Antiherpesvirus activity and mode of action of SP-303, a novel plant flavonoid. (1993) (53)
Quantitative studies on fabrics as disseminators of viruses. II. Persistence of poliomyelitis virus on cotton and wool fabrics. (1966) (53)
STUDIES OF LATENT Q FEVER INFECTIONS. II. EFFECTS OF MULTIPLE CORTISONE INJECTIONS. (1964) (53)
Anti-human cytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinone derivatives. (1995) (52)
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice. (2004) (50)
In Vitro Activity of Expanded-Spectrum Pyridazinyl Oxime Ethers Related to Pirodavir: Novel Capsid-Binding Inhibitors with Potent Antipicornavirus Activity (2004) (50)
Treatment of murine cytomegalovirus infections in severe combined immunodeficient mice with ganciclovir, (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine, interferon, and bropirimine (1992) (50)
Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice (1992) (48)
Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero (1998) (48)
Mutations in the E9L Polymerase Gene of Cidofovir-Resistant Vaccinia Virus Strain WR Are Associated with the Drug Resistance Phenotype (2006) (48)
Human influenza viral infection in utero increases nNOS expression in hippocampi of neonatal mice (1998) (47)
Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections. (1994) (46)
STUDIES ON LATENT Q FEVER INFECTIONS. I. EFFECTS OF WHOLE BODY X-IRRADIATION UPON LATENTLY INFECTED GUINEA PIGS, WHITE MICE AND DEER MICE. (1964) (46)
Antiviral Activity of Nucleoside Analogues against SARS-coronavirus (SARS-CoV) (2006) (45)
Azapurine nucleosides. 2. Synthesis and antiviral activity of 7-amino-3- -D-arabinofuranosyl-v-triazolo (4,5-d)pyrimidine and related nucleosides. (1972) (45)
Modeling hamsters for evaluating West Nile virus therapies. (2004) (44)
Antiviral Activity of 3-Deazaguanine, 3-Deazaguanosine, and 3-Deazaguanylic Acid (1977) (44)
Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. (2002) (44)
Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice (1996) (43)
Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. (2007) (42)
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus. (2003) (42)
Anti-DNA virus activity of the 5'-nucleotide and 3',5'-cyclic nucleotide of 9-beta-D-arabinofuranosyladenine. (1973) (41)
Activity of T-1106 in a Hamster Model of Yellow Fever Virus Infection (2007) (40)
Mode of inhibition of respiratory syncytial virus by a plant flavonoid, SP-303. (1993) (40)
Antiviral mechanisms of action. (1980) (40)
Viral regulation of aquaporin 4, connexin 43, microcephalin and nucleolin (2008) (39)
Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67 kDa proteins are increased in brains of neonatal BALB/c mice following viral infection in utero (2004) (39)
Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival. (2005) (38)
Treatment of Cowpox Virus Respiratory Infections in Mice with Ribavirin as a Single Agent or Followed Sequentially by Cidofovir (2000) (38)
Interferon Alfacon-1 Protects Hamsters from Lethal Pichinde Virus Infection (2005) (37)
Pharmacodynamic Evaluation of RWJ-270201, a Novel Neuraminidase Inhibitor, in a Lethal Murine Model of Influenza Predicts Efficacy for Once-Daily Dosing (2001) (37)
Effect of selenazofurin on influenza A and B virus infections of mice. (1986) (37)
Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus. (2003) (36)
Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice. (2000) (36)
Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin). (1978) (36)
Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice. (2004) (35)
Treatment of lethal Pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen. (1993) (35)
Antiviral activity of 9-beta-D-arabinofuranosyladenine. II. Activity against Herpes simplex keratitis in hamsters. (1968) (35)
Effects of ribamidine, a 3-carboxamidine derivative of ribavirin, on experimentally induced Phlebovirus infections. (1988) (34)
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus. (1995) (34)
Synthesis and antiviral and antimicrobial activity of certain 1-beta-D-ribofuranosyl-4,5-disubstituted imidazoles. (1976) (33)
Antiviral Activity of Naturally Occurring Anthraquinones and Anthraquinone Derivatives (1990) (33)
Influenza virus-inhibitory effects of intraperitoneally and aerosol-administered SP-303, a plant flavonoid. (1994) (33)
Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. (1991) (33)
Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice. (2007) (32)
Inhibition of bluetongue and Colorado tick fever orbiviruses by selected antiviral substances (1981) (32)
West Nile virus infection of the placenta. (2006) (32)
Effect of l-β-D-Ribofuranosyl-l,2,4-Triazole-3-Carboxamide (Ribavirin) on Friend Leukemia Virus Infections in Mice (1975) (31)
Quantitative studies on fabrics as disseminators of viruses. 3. Persistence of vaccinia virus on fabrics impregnated with a virucidal agent. (1967) (31)
Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment. (2008) (30)
Inhibition of Measles Virus Replication by 5′-Nor Carbocyclic Adenosine Analogues (2001) (30)
Purine Analogs as Potential Anticytomegalovirus Agents∗ (1969) (29)
Coumarins and Pyranocoumarins, Potential Novel Pharmacophores for Inhibition of Measles Virus Replication (2002) (29)
Comparative Study of the Anti-Human Cytomegalovirus Activities and Toxicities of a Tetrahydrofuran Phosphonate Analogue of Guanosine and Cidofovir (1999) (28)
Inhibition of RNA Virus Replication in Vitro by 3-Deazacytidine and 3-Deazauridine (1972) (28)
In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin. (1995) (28)
Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes. (2006) (28)
Recombinant Eimeria Protozoan Protein Elicits Resistance to Acute Phlebovirus Infection in Mice but Not Hamsters (2006) (27)
Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus. (2007) (27)
Efficacy of 9-β-d-Arabinofuranosylhypoxanthine 5′-Monophosphate in Therapy of Equine Abortion Virus-Induced Hepatitis in Hamsters (1975) (27)
Synthesis and antiviral and enzymatic studies of certain 3-deazaguanines and their imidazolecarboxamide precursors. (1978) (26)
Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice (1991) (26)
In vitro and in vivo Effect of 1-β-D-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Ribavirin) on Types 1 and 3 Para-influenza Virus Infections (1975) (26)
Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201. (2001) (26)
in vitro inhibition of the measles virus by novel ring-expanded ('fat') nucleoside analogues containing the imidazo[4,5-e]diazepine ring system. (2002) (25)
Potential Role of Immunomodulators for Treatment of Phlebovirus Infections of Animals a (1992) (25)
2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection. (1999) (25)
Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug. (2002) (25)
In vivo anti-influenza virus activity of a zinc finger peptide (1997) (24)
Characterization and Treatment of Cidofovir-Resistant Vaccinia (WR Strain) Virus Infections in Cell Culture and in Mice (2005) (23)
Target-Organ Treatment of Neurotropic Virus Diseases: Efficacy as a Chemotherapy Tool and Comparison of Activity of Adenine Arabinoside, Cytosine Arabinoside, Idoxuridine, and Trifluorothymidine (1972) (23)
Anti-Influenza Virus Activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its Derivatives (2006) (23)
Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. (1998) (23)
Quantitative studies on fabrics as disseminators of viruses. V. Effect of laundering on poliovirus-contaminated fabrics. (1971) (23)
Combinatorial Ribavirin and Interferon Alfacon-1 Therapy of Acute Arenaviral Disease in Hamsters (2006) (23)
EFFECT OF RIBAVIRIN ON VIRAL HEPATITIS IN LABORATORY ANIMALS (1977) (22)
Activity of selenazofurin against influenza A and B viruses in vitro (1985) (22)
Studies of latent Q fever infections. 3. Effects of parturition upon latently infected guinea pigs and white mice. (1966) (22)
Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine. (1975) (21)
Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201. (2001) (21)
Effects of Zidovudine on Friend Virus Complex Infection in Rfv‐3r/s Genotype‐Containing Mice Used as a Model for HIV Infection (1990) (21)
RESULTS OF A FIVE-YEAR SURVEY FOR CERTAIN ENZOOTIC DISEASES IN THE FAUNA OF WESTERN UTAH. (1965) (21)
Bioassay system for determining ribavirin levels in human serum and urine. (1981) (21)
Quantitative Studies on Fabrics as Disseminators of Viruses (1970) (21)
Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice. (2007) (20)
Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. (1999) (20)
Effect of Oral Gavage Treatment with ZnAL42 and other Metallo-Ion Formulations on Influenza a H5N1 and H1N1 Virus Infections in Mice (2007) (20)
Tularemia in the Wildlife and Livestock of the Great Salt Lake Desert Region, 1951, through 1964. (1965) (20)
BRUCELLOSIS IN WILDLIFE AND LIVESTOCK OF WEST CENTRAL UTAH. (1965) (20)
Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812). (2003) (20)
Broad-spectrum inhibitor of viruses in the Flaviviridae family. (2005) (19)
Determination of antiviral activity (1986) (19)
Comparative Effects of Cidofovir and Cyclic HPMPC on Lethal Cowpox and Vaccinia Virus Respiratory Infections in Mice (2003) (19)
Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity. (2004) (19)
Synthesis and antitumor antiviral activities of 1-.beta.-D-arabinofuranosylpyrimidine 3',5'-cyclic phosphates (1972) (19)
The Mouse Model of Influenza Virus Infection (1999) (18)
Influence of Malnutrition and Alterations in Dietary Protein on Murine Rotaviral Disease 1 (1983) (18)
Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog. (1995) (17)
Potentially infectious agents associated with shearling bedpads. I. Effect of laundering with detergent-disinfectant combinations on polio and vaccinia viruses. (1970) (17)
Selective inhibition of cytomegaloviruses by 9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)g uanine. (1993) (17)
Anti‐cowpox Virus Activities of Certain Adenosine Analogs, Arabinofuranosyl Nucleosides, and 2′‐Fluoro‐arabinofuranosyl Nucleosides (2004) (17)
Viral Keratitis-Inhibitory Effect of 9-β-d-Arabinofuranosylhypoxanthine 5′-Monophosphate (1975) (17)
Treatment of Mannan-Enhanced Influenza B Virus Infections in Mice with Oseltamivir, Ribavirin and Viramidine (2004) (17)
Experimental studies with four species of Brucella in selected wildlife, laboratory, and domestic animals. (1967) (16)
HIV-1 LTR activation model: evaluation of various agents in skin of transgenic mice. (1992) (16)
Influence of vehicle on topical efficacy of 2-acetylpyridine thiosemicarbazone and related derivatives on in vivo type 2 herpes simplex virus infections. (1990) (16)
Enhancement of Interferon Antiviral Action in L-Cells by Cyclic Nucleotides (1974) (16)
Influence of Treatment Schedule and Viral Challenge Dose on the in Vivo Influenza Virus-Inhibitory Effects of the Orally Administered Neuraminidase Inhibitor GS 4104 (1999) (16)
Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? (2008) (15)
Synthesis and biological activity of 9-beta-D-arabinofuranosyladenine cyclic 3',5'-phosphate and 9-beta-D-arabinofuranosylguanine cyclic 3',5'-phosphate. (1974) (15)
Selective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells (1996) (15)
In vitro effect of a variety of biologically active compounds on human cytomegalovirus. (1972) (15)
GS 4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B viruses in vitro (1997) (15)
Antiviral activities of tragacanthin polysaccharides on Punta Toro virus infections in mice. (1996) (15)
Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment. (1991) (14)
Experimental disease models of influenza virus infections: recent developments (2004) (14)
Failure of 1-β-d-Ribofuranosyl-1,2,4-Triazole-3-Carboxamide (Virazole, ICN 1229) to Stimulate Interferon (1973) (14)
Effect of Triacontanol on Numbers and Functions of Cells Involved in Inflammatory Responses (1992) (14)
Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A) (1987) (14)
A NEW CLASS OF POTENT GUANINE ANTIMETABOLITES, SYNTHESIS OF 3-DEAZAGUANINE, 3-DEAZAGUANOSINE, AND 3-DEAZAGUANYLIC ACID BY A NOVEL RING CLOSURE OF IMIDAZOLE PRECURSORS (1975) (14)
SYNTHESIS AND ANTIVIRAL ACTIVITY OF SOME PHOSPHATES OF THE BROAD-SPECTRUM ANTIVIRAL NUCLEOSIDE, 1-β-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CARBOXAMIDE (RIBAVIRIN) (1978) (14)
Synthesis and biological activity of certain carbamoyl and alkoxycarbonyl derivatives of adenosine 3',5'-cyclic phosphate. (1973) (14)
Effect of human, recombinant interleukin 2 on Punta Toro virus infections in C57BL/6 mice. (1991) (14)
Epidemiological aspects of venezuelan equine encephalitis virus infections. (1967) (13)
Structure-Activity Relationship of Phosphonic Acid Analogs of Acyclovir or Ganciclovir Against Human Cytomegalovirus in MRC-5 Cells (1994) (13)
Antiviral immunotoxins: antibody-mediated delivery of gelonin inhibits Pichinde virus replication in vitro. (1991) (13)
Effect of methionine enkephalin on natural killer cell and cytotoxic T lymphocyte activity in mice infected with influenza A virus. (1995) (13)
Q fever antibody response in experimentally infected wild rodents and laboratory animals. (1962) (12)
A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues. (1988) (12)
IN VIVO ANTIVIRAL ACTIVITY OF 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA. (1965) (12)
Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits the replication of human herpes viruses. (1994) (12)
Spectrum of Virus Inhibition by Consensus Interferon YM643 (2000) (12)
COMPARISON OF THE ANTICYTOMEGALOVIRUS ACTIVITY OF A GROUP OF PYRIMIDINE ANALOGS * (1970) (12)
THE OCCURRENCE OF A POSSIBLE EPIZOOTIC OF Q FEVER IN FAUNA OF THE GREAT SALT LAKE DESERT OF UTAH. (1964) (12)
Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1. (2008) (11)
Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection. (1991) (11)
EFFECT OF RIBAVIRIN ON TYPE 2 HERPESVIRUS HOMINIS (HVH/2) IN VITRO AND IN VIVO (1977) (11)
Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice. (1976) (10)
Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice. (1991) (10)
Effects of Folic Acid Malnutrition on Rotaviral Infection in Mice 1 (1984) (10)
Synthesis and antiviral activity of 4'-hydroxy-5,6,7,8-tetramethoxyflavone. (1972) (10)
Synthesis and antitumor and antiviral activities of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-iminopyrimidine and its derivatives. (1979) (10)
TLR 3 Deletion Limits Mortality and Disease Severity due to Phlebovirus Infection 1 (2006) (9)
DNA virus inhibitory activity of 1- -D-arabinofuranosylcytosine-3',5'-cyclic phosphate. (1973) (9)
In vitro studies on the antiviral activity of 1, 3-bis(2-chloroethyl)-1-nitrosourea. (1966) (9)
Procedure for the evaluation of the virucidal effectiveness of an ethylene oxide gas sterilizer. (1969) (9)
Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice. (1993) (9)
Effects of a series of purine analogs on Friend leukemia virus infections in mice. (1968) (9)
Effect of phosphonic acidanalogs of acyclovir and ganciclovir on in vitro cytomegalovirus infections (1989) (9)
Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection. (2007) (8)
Role of virucides in controlling virus dissemination by fabrics (1969) (8)
Selective cytotoxicity towards cytomegalovirus-infected cells by immunotoxins consisting of gelonin linked to anti-cytomegalovirus antibody. (1995) (8)
Potent in vitro Activity of the Albumin Fusion Type 1 Interferons (Albumin-Interferon-Alpha and Albumin-Interferon-Beta) against RNA Viral Agents of Bioterrorism and the Severe Acute Respiratory Syndrome (SARS) Virus (2008) (8)
COMPARISON OF THE DEVELOPMENT OF RESISTANT STRAINS OF TYPE 1 HERPES SIMPLEX VIRUS TO IN VITRO ANTIVIRAL ACTIVITY OF 5‐IODO‐2‐ DEOXYURIDINE OR RIBAVIRIN. (1977) (8)
Inhibition of Experimental Deoxyribonucleic Acid Virus-Induced Encephalitis by 9-β-d-Arabinofuranosylhypoxanthine 5′-Monophosphate (1975) (7)
Synthesis and anti-DNA -virus activity of the 5'-monophosphate and the cyclic 3',5'-monophosphate of 9-(beta-D-xylofuranosyl) guanine. (1976) (7)
Utilization of Alpha-1-Acid Glycoprotein Levels in the Serum as a Parameter for in Vivo Assay of Influenza Virus Inhibitors (2001) (7)
PR 879-317A enhances in vitro immune activity of peripheral blood mononuclear cells from patients with Down syndrome. (1987) (7)
Synthesis of Acyclonucleoside Phosphonates as Antiviral Agents Against Cytomegalovirus (1994) (7)
In Vitro and in Vivo Phlebovirus Inhibition by Nucleosides Related to Ribavirin (1989) (7)
Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile 2006 (1st Edition) (2006) (7)
Murine retroviral disease-enhancing effects of a pyrimidinone immunomodulator. (1992) (6)
Effects of monoclonal antibody combined with ganciclovir or (S)-1-[3-hydroxy-(2-phosphonylmethoxy)-propyl]cytosine against murine cytomegalovirus infections in cell culture and in severe combined immunodeficient mice. (1995) (6)
In vitro and in vivo effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on types 1 and 3 parainfulenza virus infections. (1975) (6)
Synthesis of Phosphonic Acid Analogs of Acyclovir (ACV) and Canciclovir (DHPG) (1989) (6)
Synthesis and anti-deoxyribonucleic acid virus activity of certain 9-beta-D-arabinofuranosyl-2-substituted adenine derivatives. (1974) (6)
Lack of suppression of resistance factors to influenza infections in mice pretreated with virazole. (1977) (6)
Herpes simplex keratitis in hamsters as a system for evaluating potential antiviral agents. (1966) (6)
Synthesis of Acyclonucleoside Phosphonates for Evaluation as Antiviral Agents (1991) (6)
In Vitro Antiviral Activity of 6-Substituted 9-β-d-Ribofuranosylpurine 3′,5′-Cyclic Phosphates (1974) (6)
Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice. (2001) (6)
Bovine leukemia virus inhibition in vitro by ribavirin (1981) (5)
Combination of antiviral immunotoxin and ganciclovir or cidofovir for the treatment of murine cytomegalovirus infections. (1996) (5)
Overview of viral agents in pediatric enteric infections (1986) (5)
Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) mice. (1992) (5)
SYNTHESIS AND ANTIVIRAL AND ANTIMICROBIAL ACTIVITY OF CERTAIN 1-β-D-RIBOFURANOSYL-4,5-DISUBSTITUTED IMIDAZOLES (1976) (5)
Potentially Infectious Agents Associated with Shearling Bedpads (1970) (5)
Inhibition of reoviruses in vitro by selected antiviral substances (1981) (5)
Chapter 15. Antiviral Agents (1981) (5)
Effect of Host Weight Loss on Friend Leukemia Virus Infections in Swiss, DBA/2, and BALB/c Mice.∗ (1965) (5)
Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides (1973) (5)
Murine cytomegalovirus-inhibitory effects of ImuVert. (1993) (5)
Antiviral activity of 9-beta-D-arabinofuranosyladenine. V. Activity against intracerebral Vaccinia virus infections in mice. (1968) (4)
Arbovirus Complement Fixing Antibodies in Sera of Wildlife of West Central Utah ∗ (1965) (4)
Activation of the human immunodeficiency virus long terminal repeat by abrasion of the skin in transgenic mice. (1994) (4)
Leukocyte Interleukin, Inj. (LI) augmentation of natural killer cells and cytolytic T-lymphocytes. (1995) (4)
Effect of oxamisole on immune parameters of mice infected with murine hepatitis. (1990) (4)
In vitro Inhibition of the Measles Virus by Novel Ring‐Expanded (“Fat”) Nucleoside Analogues Containing the Imidazo[4,5‐e][1,3]diazepine Ring System. (2003) (4)
Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T). (1992) (4)
Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A x A.By)F1 mice. (1995) (4)
In Vivo Antiviral Properties of Biologically Active Compounds (1968) (3)
SUSCEPTIBILITY OF WILD RODENTS TO EXPERIMENTAL INFECTION WITH COXIELLA BURNETII. (1963) (3)
Epidemiological Aspects of Venezuelan Equine Encephalitis Virus Infections (1967) (3)
Effect of Imexon on Friend Virus Complex Infection in Rfv‐3r/s Genotype‐Containing Mice as a Model for AIDS a (1990) (3)
Development of antiviral levels of ribavirin in serum and urine of orally treated rats. (1981) (3)
A consideration of animal models used for study of influenza virus inhibitors (2001) (3)
Development of Friend leukemia virus in spleen and plasma of Swiss mice. (1965) (3)
Animal Models for HBV Infections — Transgenic Mice (1999) (3)
Effect of immunomodulators in the hu-PBL-SCID mouse model. (1991) (3)
Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in mice. (1975) (2)
Effect of vidarabine in dimethyl sulfoxide vehicle on type 1 herpesvirus-induced cutaneous lesions in laboratory animals. (1987) (2)
Test Systems for Evaluating the Antiviral Activity of Nucleoside Analogues (1979) (2)
Models of antiviral resistance. (1995) (2)
Antiviral and Immunoenhancing Properties of 7-Thia-8-Oxoguanosine and Related Guanosine Analogues (1992) (2)
STUDIES ON INFECTIOUS DISEASES IN WILD ANIMALS IN UTAH. V. EXPERIMENTAL ROCKY MOUNTAIN SPOTTED FEVER IN THE COYOTE, CANIS LATRANS LESTES MERRIAM. (1963) (2)
SYNTHESIS AND ANTITUMOR AND ANTIVIRAL ACTIVITIES OF 1-β-D-ARABINOFURANOSYL-2-AMINO-1,4(2H)-IMINOPYRIMIDINE, AND ITS DERIVATIVES (1979) (2)
Virus Infection by the Double-Stranded RNA Protective Immunity against Punta Toro TLR 3 Is Essential for the Induction of (2007) (2)
5-membered azaheterocycles and their nucleosides. (1980) (2)
The Potential of Nucleosides as Antiviral Agents (1976) (2)
Viral Infection and Abnormal Brain Development: A DNA Microarray Study (2007) (1)
Efficacy of 5-Halogenated 2′-Deoxyuridines on Vaccinia Virus Thymidine Kinase Positive and Negative Strains, and Influence of Cell Type on Antiviral Potency (2007) (1)
In vivo regulation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice (1991) (1)
Twocellblockage of FVB/N embryo development: An artifact of cell culture (1991) (1)
SYNTHESIS AND ANTI-DEOXYRIBONUCLEIC ACID VIRUS ACTIVITY OF CERTAIN 9-BETA-D-ARABINOFURANOSYL-2-SUBSTITUTED ADENINE DERIVATIVES (1974) (1)
Experiences with biological response modifiers in animal models for AIDS (1992) (1)
Anti-respiratory syncytial virus activity of selected polyoxometalates (1995) (1)
Guinea Pig Antibody Response Following A Secondary Injection of Coxiella burnetti (1967) (1)
SYNTHESIS AND ANTIVIRAL ACTIVITY OF CERTAIN THIAZOLE C-NUCLEOSIDES (1977) (1)
The Potential Role of Cytokines in the Treatment of Viral Infections (2012) (1)
New Ribonucleosides with Surrogate Bases: Synthesis, Enzymology, Molecular Docking Studies and Antiviral Activity (2007) (1)
Effect of the combination of human recombinant alpha interferon-A/D and 2',3'-didehydro=2',3'-dideoxythymidine on murine retrovirus disease (1994) (1)
Selective inhibition ofcytomegaloviruses by 9-(3'-ethyl phosphonyl-1'-hydroxymethyl-1'-propyloxy-methyl)guanine (1993) (1)
Utilization of pulse oximetry for study of potential anti-influenza virus compounds in mice (1991) (1)
PSITTACOSIS COMPLEMENT-FIXING ANTIBODIES IN SERA FROM FAUNA OF THE GREAT SALT LAKE DESERT OF UTAH. (1964) (1)
Laundering shearling bedpads. (1972) (1)
Studies on infectious diseases in wild animals in Utah. III. Experimental Q fever in wild vertebrates. (1962) (1)
Biological Response Modifiers in Combination with Antivirals against Experimentally-Induced Virus Infections (1992) (1)
POTENTIAL NEW THERAPY FOR INFLUENZA (2002) (1)
Murine Punta Toro virus infection: a potential model for study of Hantavirusinhibitors (1995) (1)
Failure of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) to stimllate interferon. (1973) (1)
New models of murine cytomegalovirus infection in immunocompromised mice (1991) (0)
Sacrificing for the Lost Cause: General Robert E. Lee's Personal Staff (2018) (0)
The Decision Was Always My Own: Ulysses S. Grant and the Vicksburg Campaign by Timothy B. Smith (review) (2019) (0)
Lee and His Generals: Essays in Honor of T. Harry Williams ed. by Lawrence Lee Hewitt and Thomas E. Schott (review) (2014) (0)
A longitudinal investigation into utilising crosswall construction for multi-storey residential buildings (2009) (0)
Severity due to Phlebovirus Infection TLR3 Deletion Limits Mortality and Disease (2006) (0)
109. Human influenza infection in utero increases SNAP-25 expression in neonatal mice (1998) (0)
Transgenic mice as models for photo-induced gene expression: activation of human immunodeficiency virus long terminal repeat (1992) (0)
Is the Anti-Psychotic, 10-(3-(Dimethylamino)propyl)phenothiazine (Promazine), a Dangerous Drug with Which to TreatSARS Infections? Efficacy of Promazine on SARS-CoV Replication in a Mouse Model (2008) (0)
Use of Disposable Micro Tissue Culture Plates for Antiviral and Interferon Induction Studies (1971) (0)
Efﬁcacy of Orally Administered T-705 on Lethal Avian Inﬂuenza A (H5N1) Virus Infections in Mice (cid:1) (2007) (0)
SYNTHESIS AND ANTI-DNA VIRUS ACTIVITY OF THE 5′-MONOPHOSPHATE AND THE CYCLIC 3′,5′-MONOPHOSPHATE OF 9-(β-D-XYLOFURANOSYL)GUANINE (1976) (0)
Utah Science Vol. 45 No. 4, Winter 1984 (2014) (0)
Contents Vol. 41, 1995 (1995) (0)
Resistance to Friend leukemia virus in transgenic mice expressing the native Fv-4 gene. (1999) (0)
In Vivo Antiviral Activity of 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (1965) (0)
Lymphocytic Necrosis in Hamsters Inoculated with Western Equine Encephalitis Virus (2007) (0)
UTAH AGRICULTURAL EXPERIMENT STATION 97 PHOSPHORUS NEEDS OF BEEF CATTLE (2014) (0)
Recent antiviral chemotherapy publications. (1969) (0)
Cytopathic Maporal Hantavirus Infection of Vero E6 Cells (2007) (0)
Effects of a Series of Furine Analogs on Friend Leukemia Virus Infections in Mice 1 (2006) (0)
Copper Oxide-Based Filters Neutralizing Viruses in Suspensions by (2014) (0)
MAINTAINING ORDER IN THE MIDST OF CHAOS: ROBERT E. LEE'S USAGE OF HIS PERSONAL STAFF (2009) (0)
Cyotkines as Potential Therapies for Human Immunodeficiency Virus Infections (1994) (0)
SYNTHESIS AND ANTIVIRAL AND ENZYMIC STUDIES OF CERTAIN 3-DEAZAGUANINES AND THEIR IMIDAZOLECARBOXAMIDE PRECURSORS (1979) (0)
Swiss, dba/2, and balb/c mice. (1965) (0)
Development of Antiviral Drugs against Avian (H5N1) Influenza Virus (2006) (0)
Self-Contradictions and Morality: A Natural Law Critique of Deliberative Democracy (2007) (0)
1-0-D-Ribofuranosyl- 1,2,4-triazole-3-carboxamidine Hydrochloride (1992) (0)
Synthesis and antitumor and antiviral activities of 1- -D-arabinofuranosylpyrimidine 3',5'-cyclic phosphates. (1972) (0)
In vitro influenza virus-inhibitory effects of a series of germanium- orsilicon-centered polyoxometalates (1997) (0)
MultidineTM Augmentation of Natural Killer Cells and Cytolytic T Lymphocytes (1995) (0)
Development of Methods for Carrier-Mediated Targeted Delivery of Antiviral Compounds Using Monoclonal Antibodies (1987) (0)
SYNTH. UND VIRUSWIRKUNG VON 4′-HYDROXY-5,6,7,8-TETRAMETHOXYFLAVON (1973) (0)
Effects of subcutaneous treatments with cidofovir on a vaccinia virus respiratory infection in mice (2003) (0)
Synthesis of Acyclonucleoside Phosphonates as Antiviral Agents Against Cytomegalovirus. (1995) (0)
Subject Index Vol. 41, 1995 (1995) (0)
Treatment of Phlebovirus infections of mice by poly ICLC (1991) (0)
Cytokines as potential therapies for human immunodeficiency virus infections (2016) (0)
Effect of Prophylactic Treatment with ASAP-AGX-32 and ASAP Solutions on an Avian Influenza A (H5N1) Virus Infection in Mice (2007) (0)
In VivoActivation ofHumanImmunodeficiency VirusType1Long Terminal RepeatbyUV TypeA (UV-A)LightplusPsoralen andUV-BLight intheSkinofTransgenic Mice (1991) (0)
AIDS: Implications to Society and Approaches to Control (1990) (0)
Acyclic phosphonomethylether nucleosideinhibitors of respiratory viruses (1997) (0)
Transgenic mice as a chemotherapeutic model for HBV infection (1998) (0)
Effect ofI-f3-D-Ribofuran osyl-I ,2,4-Triazole.3- Carboxamide (Virazole, ICN1229) on Herpes andVaccinia Keratitis andEncephalitis inLaboratory Animals (1973) (0)
Subject Index, Vol. 37, 1994 (1994) (0)
Contents, Vol. 19, 1973 (1973) (0)
The Grounded Mind: Education and Future Shock. (1974) (0)
The effects ofhuman cytomegalovirus (HCMV) inhibitory agent, 9-(3'-phosphono-1'-hydroxymethyl-1'-propyloxymethyl)guanine (SR3745), on macromolecular synthesis and in vitro antiviral activityin human diploid cells (1989) (0)
Acknowledgement to the Reviewers (2005) (0)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF 9-BETA-D-ARABINOFURANOSYLADENINE CYCLIC 3′,5′-PHOSPHATE AND 9-BETA-D-ARABINOFURANOSYLGUANINE CYCLIC 3′,5′-PHOSPHATE (1974) (0)
SYNTHESIS AND BIOLOGICAL ACTIVITY OF CERTAIN CARBAMOYL AND ALKOXYCARBONYL DERIVATIVES OF ADENOSINE 3′,5′-CYCLIC PHOSPHATE (1974) (0)
Practical Synthesis of (−)-Carbocyclic Cytosine (Carbodine) and its In Vitro Antiviral Activity against Venezuelan Equine Encephalitis (VEE) Virus and Yellow Fever Virus (2007) (0)
Anti-humancytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinonederivatives (1995) (0)
Contents, Vol. 37, 1994 (1994) (0)
Procedure fortheEvaluation oftheVirucidal Effectiveness ofan Ethylene OxideGasSterilizer (1969) (0)
Inhibition ofBluetongue andColorado TickFeverOrbiviruses bySelected Antiviral Substancest (1981) (0)
N4-beta-d-ribofuranosyltrianzin-3-one-n1-oxide (icn 3520), a new uridine antagonist exhibiting antitumor activity. Abstr. (1973) (0)
Immunomodulatory Effects of Methionine-Enkephalin in Influenza Infected Mice (1995) (0)
Determination of the In Vitro and In Vivo Activity of Compounds Tested Against Punta Toro Virus. (1987) (0)
Inhibition ofMurineHepatitis Virus Infections bythe Immunomodulator 2,3,5,6,7,8-Hexahydro-2-Phenyl-8,8-Dimethoxy- (1987) (0)
SYNTHESIS AND ANTIVIRAL ACTIVITY OF CERTAIN 5′-MONOPHOSPHATES OF 9-ARABINOFURANOSYLHYPOXANTHINE AND 9-D-ARABINOFURANOSYLHYPOXANTHINE (1975) (0)
The effect of treatment with a combination of 6-mercaptopurine and porfiromycin on an established Friend leukemia virus infection. (1969) (0)
Procedure for the Evaluation of the Virucidal Effectiveness of an Ethylene Oxide Gas Sterilizer (1969) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert William Sidwell?

Robert William Sidwell is affiliated with the following schools:

Robert William Sidwell's Academic­Influence.com Rankings